AIDS-related myopathy

Medical Molecular Morphology

Volumn 32, Issue 2, 1999, Pages 79-86

  Sheikh, Rafiq A ^a   Yasmeen, Shagufta ^a   Munn, Robert ^a   Ruebner, Boris H ^a   Ellis, William G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Electron microscopy; HIV; Myopathy; Nucleoside analogs; Zidovudine

Indexed keywords

ACICLOVIR; DEXTROPROPOXYPHENE; FAT DROPLET; PREDNISONE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MALE; MITOCHONDRIAL MYOPATHY; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE FIBRIL; MUSCLE NECROSIS; MYOPATHY; MYOSITIS; NEMALINE MYOPATHY; PRIORITY JOURNAL; PYOMYOSITIS; RHABDOMYOLYSIS;

EID: 0032698499     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s007950050012     Document Type: Review

References (61)

1. Chariot P, Gherardi R (1995) Myopathy and HIV infection. Current Opin Rheumatol 7:497-502
2. Dwyer BA, Mayer RF, Lee SC (1992) Progressive nemaline (rod) myopathy as a presentation of human immunodeficiency virus infection [letter]. Arch Neurol 49:440
3. Chariot P, Ruet E, Authier FJ, Levy Y, Gherardi R (1994) Acute rhabdomyolysis in patients infected by human immunodeficiency virus. Neurology 44:1692-1696
4. Simpson DM, Bender AN (1988) Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol 24:79-84
5. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 1987 36(Suppl 1):1S-15S
6. Dalakas MC, Pezeshkpour GH (1988) Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol 23(Suppl):S38-48
7. Wrzolek MA, Sher JH, Kozlowski PB, Rao C (1990) Skeletal muscle pathology in AIDS: an autopsy study. Muscle Nerve 13:508-515
8. Simpson DM, Citak KA, Godfrey E, Godbold J, Wolfe DE (1993) Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? [See comments]. Neurology 43:971-976
9. Bessen LJ, Greene JB, Louie E, Seitzman P, Weinberg H (1988) Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC [letter]. New Engl J Med 318:708
10. Grau JM, Masanes F, Pedrol E, Casademont J, Fernandez-Sola J, Urbano-Marquez A (1993) Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy [see comments]. Ann Neurol 34:206-211
11. Manji H, Harrison MJ, Round JM, Jones DA, Connolly S, Fowler CJ, Williams I, Weller IV (1993) Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine. J Neurol 240:479-488
12. Miller RG, Carson PJ, Moussavi RS, Green AT, Baker AJ, Weiner MW (1991) Fatigue and myalgia in AIDS patients. Neurology 41:1603-1607
13. Till M, MacDonell KB (1990) Myopathy with human immunodeficiency virus types 1 (HIV-1) infection: HIV-1or zidovudine? Ann Intern Med 113:492-494
14. Von Oren JH (1994) Management of HIV-related body weight loss. Drugs 47:774-783
15. Grunfeld C, Feingold KR (1992) Metabolic disturbances and wasting in the acquired immunodeficiency syndrome [see comments]. New Engl J Med 327:329-337
16. Chan IS, Neaton JD, Saravolatz LD, Crane LR, Osterberger J (1995) Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS. AIDS 9:1145-1151
17. Dalakas MC, Yarchoan R, Spitzer R, Elder G, Sever JL (1988) Treatment of human immunodeficiency virus-related polyneuropathy with 3′-azido- 2′,3′-dideoxythymidine. Ann Neurol 23(Suppl):S92-94
18. Ilia I, Nath A, Dalakas M (1991) Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 29:474-481
19. Wiley CA, Nerenberg M, Cros D, Soto-Aguilar MC (1989) HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus. New Engl J Med 320:992-995
20. Leon-Monzon M, Lamperth L, Dalakas MC (1993) Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis. Muscle Nerve 16:408-413
21. Seidman R, Peress NS, Nuovo GJ (1994) In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids in skeletal muscle in patients with myopathy. Mod Pathol 7:369-375
22. Gherardi RK, Florea-Strat A, Fromont G, Poron F, Sabourin JC, Authier J (1994) Cytokine expression in the muscle of HIV-infected patients: evidence of interleukin-1 alpha accumulation in mitochondria of AZT fibers. Ann Neurol 36:752-758
23. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee [see comments] [published erratum appears in Lancet 1996 348:834]. Lancet 1996 348:283-291
24. Chen CH, Vazquez-Padua M, Cheng YC (1991) Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol 39:625-628
25. Dalakas MC, Ilia I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by long-term zidovudine therapy [see comments]. New Engl J Med 322:1098-1105
26. Pezeshkpour G, Ilia I, Dalakas MC (1991) Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Hum Pathol 22:1281-1288
27. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337:508-510
28. Lewis W, Dalakas MC (1995) Mitochondrial toxicity of antiviral drugs. Nature Medicine 1:417-422
29. Chariot P, Ruet E, Authier FJ, Labes D, Poron F, Gherardi R (1996) Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies. Acta Neuropathologica 91:530-536
30. Chariot P, Monnet I, Gherardi R (1993) Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy. Ann Neur 34:561-565
31. Dalakas MC, Pezeshkpour GH, Flaherty M (1987) Progressive nemaline (rod) myopathy associated with HIV infection [letter]. New Engl J Med 317:1602-1603
32. Chattha G, Arieff AI, Cummings C, Tierney LM Jr (1993) Lactic acidosis complicating the acquired immunodeficiency syndrome [see comments]. Ann Intern Med 118:37-39
33. Le Bras P, D'Oiron R, Quertainmont Y, Halfon P, Caquet R (1994) Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease? [letter]. AIDS 8:716-717
34. Olano JP, Borucki MJ, Wen JW, Haque AK (1995) Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin Infect Dis 21:973-976
35. Dalakas MC, Leon-Monzon ME, Bernardini I, Gahl WA, Jay CA (1994) Zidovudine-induced mitochondrial myopathy is associated with muscle Carnitine deficiency and lipid storage [see comments]. Ann Neurol 35:482-487
36. Chlebowski RT (1985) Significance of altered nutritional status in acquired immune deficiency syndrome (AIDS). Nutr Cancer 7:85-91
37. O'Sullivan P, Linke RA, Dalton S (1985) Evaluation of body weight and nutritional status among AIDS patients. J Am Diet Assoc 85:1483-1484
38. Coodley GO, Loveless MO, Merrill TM (1994) The HIV wasting syndrome: a review. J Acqui Immune Defic Syndr 7:681-694
39. Berger JR, Pall L, Winfield D (1993) Effect of anabolic steroids on HIV-related wasting myopathy. South Med J 86:865-866
40. Simpson DM, Tagliati M (1994) Neurologic manifestations of HIV infection [published erratum appears in Ann Intern Med 1995 122:317] [see comments]. Ann Intern Med 121:769-785
41. Von Roenn JH, Murphy RL, Wegener N (1990) Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection. Semin Oncol 17(6) (Suppl 9):13-16
42. Weinroth SE, Parenti DM, Simon GL (1995) Wasting syndrome in AIDS: pathophysiologic mechanisms and therapeutic approaches. Infect Agents Dis 4:76-94
43. Hellerstein MK, Kahn J, Mudie H, Viteri F (1990) Current approach to the treatment of human immunodeficiency virus-associated weight loss: pathophysiologic considerations and emerging management strategies. Semin Oncol 17(6) (Suppl 9):17-33
44. Sharp M, Getty J, Klausner JD (1997) Thalidomide use is associated with weight gain in HIV-1-positive clients [letter]. J Acquir Immun Defic Syndr Hum Retrovirol 15:392
45. Reyes-Teran G, Sierra-Madero JG, Martinez del Cerro V, Arroyo-Figueroa H, Pasquetti A, Calva JJ, Ruiz-Palacios GM (1996) Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial. AIDS 10:1501-1507
46. Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, Mosdell KW, shepard KV (1997) Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manag 14:7-14
47. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB (1996) Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group [see comments]. Ann Intern Med 125:873-882
48. Windisch PA, Papatheofanis FJ, Matuszewski KA (1998) Recombinant human growth hormone for AIDS-associated wasting. Ann Pharmacother 32:437-445
49. Berger JR, Pall L, Hall CD, Simpson DM, Berry PS, Dudley R (1996) Oxandrolone in AIDS-wasting myopathy. AIDS 10:1657-1662
50. Cabello A, Martinez-Martin P, Gutierrez-Rivas E, Madero S (1990) Myopathy with nemaline structures associated with HIV infection. J Neurol 237:64-65
51. Feinberg DM, Spiro AJ, Weidenheim KM (1998) Distinct light microscopic changes in human immunodeficiency virus-associated nemaline myopathy. Neurology 50:529-531
52. Major NM, Tehranzadeh J. Musculoskeletal manifestations of AIDS (1997) Radiol Clin North Am 35:1167-1189
53. Belec L, Di Costanzo B, Georges AJ, Gherardi R (1991) HIV infection in African patients with tropical pyomyositis [letter]. AIDS 5:234
54. Vilades C, Garcia-Queralt R, Rivas I, Vidal F, Richart C (1994) Pyomyositis due to Escherichia coli in a patient infected by HIV [letter]. Br J Rheumatol 33:404-405
55. Diego Miralles G, Bregman Z (1994) Necrotizing pyomyositis caused by Mycobacterium avium complex in a patient with AIDS [letter]. Clin Infect Dise 18:833-834
56. Fleckenstein JL, Burns DK, Murphy FK, Jayson HT, Bonte FJ (1991) Differential diagnosis of bacterial myositis in AIDS: evaluation with MR imaging. Radiology 179:653-658
57. Gherardi RK, Baudrimont M, Lionet F, Salord JM, Duvivier C, Michon C, Wolff M, Marche C (1992) Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 32:535-542
58. Chariot P, Perchet H, Monnet I (1999) Dilated cardiomyopathy in HIV-infected patients [letter]. New Engl J Med 340:732; discussion 733-735
59. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G (1998) Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS [see comments]. New Engl J Med 339:1093-1099
60. Chevalier X, Amoura Z, Viard JP, Souissi B, Sobel A, Gherardi R (1993) Skeletal muscle lymphoma in patients with the acquired immunodeficiency syndrome: a diagnostic challenge. Arthr Rheum 36:426-427
61. Authier FJ, De Grissac N, Degos JD, Gherardi RK (1995) Transient myasthenia gravis during HIV infection. Muscle Nerve 18:914-916